This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat ...
Ducharme is a contributor to TIME. Ducharme is a contributor to TIME. Soon after she started taking the drug methotrexate in February, Jennifer Crow noticed a significant improvement in her ...
Patients who take methotrexate for a variety of immune-mediated inflammatory diseases and pause taking the drug following receipt of a COVID-19 vaccine dose did not have a higher risk of disease flare ...
NEW YORK CITY -- Postoperative intravitreal methotrexate for retinal detachment led to a significant reduction in reoperation and improved visual acuity, a retrospective chart review showed. The ...
When Becky Schwarz saw the message in her patient portal saying she could no longer receive a prescription for methotrexate to treat her lupus, she felt surprised. It was only six days after the U.S.
LONG BEACH, Calif. -- Methotrexate, during and after surgery for primary retinal detachment, has produced "amazing" early results in preventing proliferative vitreoretinopathy (PVR), according to ...
Please provide your email address to receive an email when new articles are posted on . “If providers treating PMR are having difficulty tapering people off steroids without concomitant ...
Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...
Please provide your email address to receive an email when new articles are posted on . “The disease-modifying anti-rheumatic drug methotrexate is the standard-of-care treatment of inflammatory ...
Verywell Health on MSN
Does methotrexate cause weight gain?
Medically reviewed by Anita C. Chandrasekaran, MD Key Takeaways Methotrexate may cause modest weight gain, especially if you are underweight when you start treatment.If you gain weight on methotrexate ...
January 28, 2008 — New research shows that high-dose methotrexate is the most effective drug for primary central nervous system lymphoma (PCNSL), with up to 20% of patients achieving a long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results